Uncategorized

At the American Society of Nephrology (ASN) Kidney Week this year, DaVita Clinical Research’s study “Exploring Patient Perspectives on Reasons for Missing Dialysis Treatments” shed vital light on this challenge.   The research reveals that 63% of missed treatments stem from acute, same-day circumstances — most often health symptoms rather than logistical or scheduling conflicts.   In […]

DaVita Inc. (NYSE: DVA) today announced that its Chief Financial Officer, Joel Ackerman, and its Group Vice President of Investor Relations, Nic Eliason, will participate in fireside chats at the…

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2026. Financial and operating highlights for the quarter ended September 30, 2026:…

Nearly 1,000 people screened in Houston and Los Angeles, with a majority showing signs of elevated chronic disease risk DENVER, Oct. 27, 2026 /PRNewswire/ — Millions of Americans are living with…

DaVita today issued the following statement in response to the U.S. Department of Health and Human Services’ Kidney Care National Plan and related remarks regarding the future of kidney care:…